Skip to main content
GutCited

説明

Metabolite profiling of fecal samples from IBS patients receiving human milk oligosaccharides, revealing shifts in short-chain fatty acid production and other microbial metabolites.

Cite This Figure

![Figure 3: Metabolite profiling of fecal samples from IBS patients receiving human milk oligosaccharides, revealing shifts in short-chain fatty acid production and other microbial metabolites.]()

> Source: Cristina Iribarren et al. "The Effects of Human Milk Oligosaccharides on Gut Microbiota, Metabolite Profile." *Nutrients*, 2021. PMID: [34836092](https://pubmed.ncbi.nlm.nih.gov/34836092/)
<figure>
  <img src="" alt="Metabolite profiling of fecal samples from IBS patients receiving human milk oligosaccharides, revealing shifts in short-chain fatty acid production and other microbial metabolites." />
  <figcaption>Figure 3. Metabolite profiling of fecal samples from IBS patients receiving human milk oligosaccharides, revealing shifts in short-chain fatty acid production and other microbial metabolites.<br>  Source: Cristina Iribarren et al. "The Effects of Human Milk Oligosaccharides on Gut Microbiota, Metabolite Profile." <em>Nutrients</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34836092/">34836092</a></figcaption>
</figure>